CoChat

Screening of compounds to identify novel epigenetic regulatory factors that affect innate immune memory in macrophages

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Trained immunity and tolerance are part of the innate immune memory that allow innate immune cells to differentially respond to a second encounter with stimuli by enhancing or suppressing responses. In trained immunity, treatment of macrophages with β-glucan (BG) facilitates the production of proinflammatory cytokines upon lipopolysaccharide (LPS) stimulation. For the tolerance response, LPS stimulation leads to suppressed inflammatory responses during subsequent LPS exposure. Epigenetic reprogramming plays crucial roles in both phenomena, which are tightly associated with metabolic flux. In this study, we performed a screening of an epigenetics compound library that affects trained immunity or LPS tolerance in macrophages using TNFα as a readout. Among the 181 compounds tested, one compound showed suppressive effects, while 2 compounds showed promoting effects on BG-trained TNFα production. In contrast, various inhibitors targeting Aurora kinase, histone methyltransferase, histone demethylase, histone deacetylase and DNA methyltransferase showed inhibitory activity against LPS tolerance. Several proteins previously unknown to be involved in innate immune memory, such as MGMT, Aurora kinase, LSD1 and PRMT5, were revealed. Protein network analysis revealed that the trained immunity targets are linked via Trp53, while LPS tolerance targets form three clusters of histone-modifying enzymes, cell division and base-excision repair. In trained immunity, the histone lysine methyltransferase SETD7 was identified, and its expression was increased during BG treatment. Level of the histone lysine demethylase, LSD1, increased during LPS priming and siRNA-mediated reduction resulted in increased expression of Il1b in LPS tolerance. Taken together, this screening approach confirmed the importance of epigenetic modifications in innate immune memory and provided potential novel targets for intervention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-022-05929-x

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generating BG-trained and LPS-tolerant macrophages. (a) Protocol to induce BG-trained or LPS-tolerant macrophages using BMM. (b) TNFα production was detected by ELISA in unstimulated cells, BG-primed cells, or LPS-primed cells at 24 h and in LPS-stimulated naïve cells (crtl), LPS-stimulated BG-primed cells (trained) or LPS-stimulated LPS-primed cells (tolerant) after 24 h of stimulation. The relative fold changes were calculated by normalizing to the amount obtained from LPS-stimulated naïve BMMs (10 ng/ml). (c) Protocol to induce BG-trained or LPS-tolerant macrophages using BMM and the indicated time for cell lysate collection. (d–g) Levels of H3K4me3 and H3K27me3 normalized to total histones in BMMs treated as indicated in (c) as detected by Western blot. *, **, and *** indicate significant differences compared by two-tailed unpaired t-tests at p < 0.05, p < 0.01 and p < 0.001, respectively.
Figure 1 Generating BG-trained and LPS-tolerant macrophages. (a) Protocol to induce BG-trained or LPS-tolerant macrophages using BMM. (b) TNFα production was detected by ELISA in unstimulated cells, BG-primed cells, or LPS-primed cells at 24 h and in LPS-stimulated naïve cells (crtl), LPS-stimulated BG-primed cells (trained) or LPS-stimulated LPS-primed cells (tolerant) after 24 h of stimulation. The relative fold changes were calculated by normalizing to the amount obtained from LPS-stimulated naïve BMMs (10 ng/ml). (c) Protocol to induce BG-trained or LPS-tolerant macrophages using BMM and the indicated time for cell lysate collection. (d–g) Levels of H3K4me3 and H3K27me3 normalized to total histones in BMMs treated as indicated in (c) as detected by Western blot. *, **, and *** indicate significant differences compared by two-tailed unpaired t-tests at p < 0.05, p < 0.01 and p < 0.001, respectively.CC BY · PubMed Central
Figure 2 Compounds that showed enhanced or suppressed TNFα production in BG-trained and LPS-tolerant macrophages. (a) The relative fold changes of TNFα produced from compound-treated BG-trained macrophages (priming step or stimulation step) were calculated by normalizing to the amount of TNFα produced from vehicle control treatment of BG-trained macrophages. Average fold changes of two biological replicates are shown as heatmap format. Only compounds that increased the relative fold changes of TNFα more than 1.5-fold or lower than 0.75-fold are shown. (b) The relative fold changes of TNFα produced from compound-treated LPS-tolerant macrophages (priming step or stimulation step) were calculated by normalizing to the amount of TNFα produced from vehicle control treatment of LPS-tolerant macrophages. The fold changes are the average of two biological replicates and shown as heatmap format. Only compounds that increased the relative fold changes of TNFα more than 1.5-fold are shown. (c) Targets of suppressing inhibitors were classified based on function and time point.
Figure 2 Compounds that showed enhanced or suppressed TNFα production in BG-trained and LPS-tolerant macrophages. (a) The relative fold changes of TNFα produced from compound-treated BG-trained macrophages (priming step or stimulation step) were calculated by normalizing to the amount of TNFα produced from vehicle control treatment of BG-trained macrophages. Average fold changes of two biological replicates are shown as heatmap format. Only compounds that increased the relative fold changes of TNFα more than 1.5-fold or lower than 0.75-fold are shown. (b) The relative fold changes of TNFα produced from compound-treated LPS-tolerant macrophages (priming step or stimulation step) were calculated by normalizing to the amount of TNFα produced from vehicle control treatment of LPS-tolerant macrophages. The fold changes are the average of two biological replicates and shown as heatmap format. Only compounds that increased the relative fold changes of TNFα more than 1.5-fold are shown. (c) Targets of suppressing inhibitors were classified based on function and time point.CC BY · PubMed Central
Figure 3 Possible interactions among the target proteins for the identified inhibitors. Potential interactions among target proteins of inhibitors identified in the screening for tolerance (a) and trained immunity (b) by STRING. The target proteins of inhibitors identified in this study are shown in black text while the potential functional partner proteins are shown in gray text. The interactions among proteins that are experimentally determined are linked with pink lines while the interactions predicted from curated database are shown in blue. Effective targets related to previous studies are represented in blue text.
Figure 3 Possible interactions among the target proteins for the identified inhibitors. Potential interactions among target proteins of inhibitors identified in the screening for tolerance (a) and trained immunity (b) by STRING. The target proteins of inhibitors identified in this study are shown in black text while the potential functional partner proteins are shown in gray text. The interactions among proteins that are experimentally determined are linked with pink lines while the interactions predicted from curated database are shown in blue. Effective targets related to previous studies are represented in blue text.CC BY · PubMed Central
Figure 4 Expression profiles of Aurora kinases in LPS-tolerant macrophages. LPS-tolerant macrophages were prepared as described above. (a) IL-6 production after treatment with selected inhibitors from Fig. 3a was measured by ELISA at 24 h after LPS stimulation. (b, c) Cell viability was detected by MTT assay at 24 h after treatment with inhibitors from (a). (d-f) Phosphorylation of Aurora kinases was analyzed by Western blot. The relative intensity from Western blot was quantitated by ImageJ analysis and normalized to β-actin. *, **, *** and **** indicate significant differences compared by one-way ANOVA with Dunnett’s multiple comparison test (a) and two-tailed unpaired t-test (d) at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.
Figure 4 Expression profiles of Aurora kinases in LPS-tolerant macrophages. LPS-tolerant macrophages were prepared as described above. (a) IL-6 production after treatment with selected inhibitors from Fig. 3a was measured by ELISA at 24 h after LPS stimulation. (b, c) Cell viability was detected by MTT assay at 24 h after treatment with inhibitors from (a). (d-f) Phosphorylation of Aurora kinases was analyzed by Western blot. The relative intensity from Western blot was quantitated by ImageJ analysis and normalized to β-actin. *, **, *** and **** indicate significant differences compared by one-way ANOVA with Dunnett’s multiple comparison test (a) and two-tailed unpaired t-test (d) at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.CC BY · PubMed Central
Figure 5 Expression profiles of SETD7 during BG-trained responses in macrophages. BG-trained macrophages were prepared as described above. (a) The mRNA expression profile of Setd7 was detected by qRT-PCR. (b, c) Cell lysates were analyzed by Western blot. The relative intensity of SETD7 from Western blot was quantitated by ImageJ analysis and normalized to β-actin. The relative intensity was calculated using unstimulated samples as the baseline. (d, e) Effect of cyproheptadine (CPH) on TNFα and IL-6 production in BG-trained macrophages after LPS stimulation. (f) Cell viability from the MTT assay in BG-primed macrophages after treatment with different concentrations of CPH for 24 h. *, **, *** and **** indicate significant differences compared by one-way ANOVA with Tukey’s multiple test at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.
Figure 5 Expression profiles of SETD7 during BG-trained responses in macrophages. BG-trained macrophages were prepared as described above. (a) The mRNA expression profile of Setd7 was detected by qRT-PCR. (b, c) Cell lysates were analyzed by Western blot. The relative intensity of SETD7 from Western blot was quantitated by ImageJ analysis and normalized to β-actin. The relative intensity was calculated using unstimulated samples as the baseline. (d, e) Effect of cyproheptadine (CPH) on TNFα and IL-6 production in BG-trained macrophages after LPS stimulation. (f) Cell viability from the MTT assay in BG-primed macrophages after treatment with different concentrations of CPH for 24 h. *, **, *** and **** indicate significant differences compared by one-way ANOVA with Tukey’s multiple test at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.CC BY · PubMed Central
Figure 6 Expression profiles of LSD1 during LPS tolerance in macrophages. BMMs were induced to become LPS tolerance as described above. (a, b) Expression profiles was analyzed by Western blot. The relative intensity of LSD1 from Western blot was quantitated by ImageJ analysis and normalized to β-actin. (c, d) Effect of OG-L002 on TNFα and IL-6 production in LPS-tolerant macrophages. (e, f) Effect of OG-L002 on H3K4me3 enrichment in Tnf and Il6 promoter of LPS-tolerant macrophages at 6 h after LPS stimulation. *, **, *** and **** indicate significant differences compared by one-way ANOVA with Tukey’s multiple test (c,d) and two-tailed unpaired t-test (e, f) at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.
Figure 6 Expression profiles of LSD1 during LPS tolerance in macrophages. BMMs were induced to become LPS tolerance as described above. (a, b) Expression profiles was analyzed by Western blot. The relative intensity of LSD1 from Western blot was quantitated by ImageJ analysis and normalized to β-actin. (c, d) Effect of OG-L002 on TNFα and IL-6 production in LPS-tolerant macrophages. (e, f) Effect of OG-L002 on H3K4me3 enrichment in Tnf and Il6 promoter of LPS-tolerant macrophages at 6 h after LPS stimulation. *, **, *** and **** indicate significant differences compared by one-way ANOVA with Tukey’s multiple test (c,d) and two-tailed unpaired t-test (e, f) at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.CC BY · PubMed Central
Figure 7 Effect of LSD1 silencing on LPS-tolerant macrophages. BMMs were transfected with 50 nM of siRNA lsd1 or Non-Target (NT) siRNA as described in “Materials and methods”. (a, b) Level of LSD1 at 48 h after siRNA transfection was detected by Western blot and qRT-PCR. (c) Expression of pro-inflammatory and anti-inflammatory cytokines in lsd1 silencing LPS-tolerant macrophages at 6 h after LPS stimulation. *, **, *** and **** indicate significant differences compared by two-tailed unpaired t-test at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.
Figure 7 Effect of LSD1 silencing on LPS-tolerant macrophages. BMMs were transfected with 50 nM of siRNA lsd1 or Non-Target (NT) siRNA as described in “Materials and methods”. (a, b) Level of LSD1 at 48 h after siRNA transfection was detected by Western blot and qRT-PCR. (c) Expression of pro-inflammatory and anti-inflammatory cytokines in lsd1 silencing LPS-tolerant macrophages at 6 h after LPS stimulation. *, **, *** and **** indicate significant differences compared by two-tailed unpaired t-test at p < 0.05, p < 0.01, p < 0.001 and p < 0.0001, respectively.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Cited by

Metadata

Authors
Benjaskulluecha, S., Boonmee, A., Pattarakankul, T., Wongprom, B., Klomsing, J., & Palaga, T.
Affiliations
Chulalongkorn University (TH)
Corresponding author
Palaga, Tanapat
Venue
Scientific Reports
Published
2022-02-03
Volume
12
Issue
1
Pages
1912-1912
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4210617755
Cited by
34
References
51
Citations by year
2026: 9 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 4
FWCI
2.39
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Chulalongkorn University (The 100th Anniversary Chulalongkorn University Fund for Doctoral Scholarship, C2F Postdoctoral Fellowship, Ratchadaphisek Somphoch Endowment Fund from Chulalongkorn University (760001-HR))
  • National Research Council of Thailand
  • Thailand Science Research and Innovation Fund (CU_FRB640001_01_23_1)
  • Program Management Unit for Human Resources & Institutional Development, Research and Innovation
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
trained immunity, endotoxin tolerance, macrophages, epigenetic reprogramming, β-glucan, PRMT5, MGMT, Aurora kinases, histone deacetylase, DNA methyltransferases, histone methyltransferase, histone demethylase, IL1B, Trp53, epigenetic drug targets
MeSH terms
Immunomodulating Agents, Animals, Cells, Cultured, Female, Immune Tolerance, Immunity, Innate, Immunologic Memory, Lipopolysaccharides, Macrophage Activation, Macrophages, Mice, Inbred C57BL, Histone-Lysine N-Methyltransferase, Tumor Necrosis Factor-alpha, Epigenesis, Genetic, beta-Glucans, Cell Proliferation, Mice, Interleukin-1beta, Histone Demethylases, Protein Interaction Maps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.